J Gynecol Oncol.  2022 Sep;33(5):e70. 10.3802/jgo.2022.33.e70.

Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy

Affiliations
  • 1Department of Medicine, The University of British Columbia, Vancouver, BC, Canada
  • 2Department of Radiation Oncology, BC Cancer - Vancouver, Vancouver, BC, Canada
  • 3Department of Medical Physics, BC Cancer - Vancouver, Vancouver, BC, Canada
  • 4Department of Radiation Oncology, BC Cancer - Prince George, Prince George, BC, Canada
  • 5Department of Radiation Oncology, BC Cancer - Kelowna, Kelowna, BC, Canada
  • 6Department of Radiation Oncology, BC Cancer - Surrey, Surrey, BC, Canada
  • 7Department of Medical Oncology, BC Cancer - Vancouver, Vancouver, BC, Canada
  • 8Department of Population Oncology, BC Cancer - Vancouver, Vancouver, BC, Canada

Abstract


Objective
To evaluate gastrointestinal (GI) patient reported outcomes (PROs) in cervical cancer patients treated with definitive radiotherapy (RT), comparing 3D conformal RT (3DCRT) vs. intensity modulated/volumetric modulated arc therapy (IMRT/VMAT).
Methods
An analysis of patients treated with definitive RT between 2015–2018 was performed. GI PROs were prospectively collected at baseline, during RT (acute), ≤12 weeks after RT (subacute), and >12 weeks after RT (late). GI PROs evaluated three symptom domains: bowel problems (BPs), bowel bother (BB), and abdominal problems (APs). Multiple linear regression analysis was performed to investigate associations between mean changes of symptom scores with clinical and dosimetric variables.
Results
The cohort included 167 patients. A total of 100 (60%) patients were treated with IMRT/VMAT and 67 (40%) with 3DCRT. In the subacute phase, the mean change of symptom scores from baseline in 3DCRT vs. IMRT/VMAT were +0.9 vs. −1.15 (p=0.004) for BP, +2.18 vs. −0.10 (p=0.019) for BB, and +1.41 vs. −0.38 (p=0.021) for AP. Likewise, in the late phase, mean changes were +0.72 vs. −0.82 (p=0.014) for BP, +1.98 vs. −0.03 (p=0.008) for BB, and +1.29 vs. −0.31 (p<0.001) for AP. On multiple linear regression, use of 3DCRT vs. IMRT/VMAT was associated with greater mean changes in subacute BP (p=0.023) and late phase AP (p=0.019). A higher small bowel V50Gy was associated increased symptom scores in late AP (p=0.012).
Conclusion
3DCRT was associated with significantly greater worsening of GI PRO symptom scores in the subacute and late phase. These data support the ongoing use of IMRT/VMAT in routine practice.

Keyword

Cervical Cancer; Patient Reported Outcome Measures; Gastrointestinal Tract; Abnormalities; Radiation Induced; Radiotherapy,Conformal; Radiotherapy, Intensity-Modulated
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr